Michael Fluck
Muenster, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma: clinical activity and safety results from AliCe, a single-arm multicentre phase II DeCOG trial.
Journal: The British journal of dermatology
Published: April 08, 2025
Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma.
Journal: Journal for immunotherapy of cancer
Published: November 24, 2024
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial.
Journal: Lancet (London, England)
Published: November 15, 2022
Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial.
Journal: Lancet (London, England)
Published: July 18, 2022
Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial.
Journal: Lancet (London, England)
Published: November 07, 2019
Erratum to: Vogt-Koyanagi-Harada-like uveitis under immune checkpoint inhibitor treatment for metastasized malignant melanoma
Journal: Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
Published: October 20, 2019
Vogt-Koyanagi-Harada-like uveitis under immune checkpoint inhibitor treatment for metastasized malignant melanoma
Journal: Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
Published: September 07, 2019
Tolerability of BRAF/MEK inhibitor combinations: adverse event evaluation and management.
Journal: ESMO open
Published: January 15, 2019
The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter study.
Journal: Oncotarget
Published: February 28, 2018
Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial.
Journal: Oncotarget
Published: March 06, 2017
Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 21, 2016
Use of complementary medicine in metastatic melanoma patients treated with ipilimumab within a clinical trial.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: April 28, 2016
Last Updated: 09/26/2026